Full Text:   <1795>

CLC number: R69

On-line Access: 2011-06-07

Received: 2010-10-17

Revision Accepted: 2011-02-13

Crosschecked: 2011-04-28

Cited: 0

Clicked: 5158

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2011 Vol.12 No.6 P.455-459

http://doi.org/10.1631/jzus.B1000363


Effect of tadalafil in chronic renal failure rabbits: relevance to erectile dysfunction


Author(s):  Meng-yuan Zhang, Qiang Fu, Wei Bian

Affiliation(s):  Department of Urology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China

Corresponding email(s):   im_fuqiang@yahoo.com

Key Words:  Chronic renal failure, Erectile dysfunction, Phosphodiesterase inhibitor, Tadalafil


Meng-yuan Zhang, Qiang Fu, Wei Bian. Effect of tadalafil in chronic renal failure rabbits: relevance to erectile dysfunction[J]. Journal of Zhejiang University Science B, 2011, 12(6): 455-459.

@article{title="Effect of tadalafil in chronic renal failure rabbits: relevance to erectile dysfunction",
author="Meng-yuan Zhang, Qiang Fu, Wei Bian",
journal="Journal of Zhejiang University Science B",
volume="12",
number="6",
pages="455-459",
year="2011",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1000363"
}

%0 Journal Article
%T Effect of tadalafil in chronic renal failure rabbits: relevance to erectile dysfunction
%A Meng-yuan Zhang
%A Qiang Fu
%A Wei Bian
%J Journal of Zhejiang University SCIENCE B
%V 12
%N 6
%P 455-459
%@ 1673-1581
%D 2011
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1000363

TY - JOUR
T1 - Effect of tadalafil in chronic renal failure rabbits: relevance to erectile dysfunction
A1 - Meng-yuan Zhang
A1 - Qiang Fu
A1 - Wei Bian
J0 - Journal of Zhejiang University Science B
VL - 12
IS - 6
SP - 455
EP - 459
%@ 1673-1581
Y1 - 2011
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1000363


Abstract: 
It is of great importance to investigate an effective and reliable medication against chronic renal failure (CRF)-related erectile dysfunction (ED), which aims to improve patients’ life qualities. The concentrations of cyclic guanosine monophosphate (cGMP) in the corpus cavernosal smooth muscle of both CRF and control rabbits were measured. The effects of various concentrations of tadalafil, papaverine, and sodium nitroprusside on the relaxation responses of corpus cavernosal smooth muscle pre-contracted with phenylephrine in CRF rabbits were observed. There was significant difference in the concentration of cGMP between CRF and control rabbits (P<0.01). tadalafil had the greatest impacts on CRF rabbits when given the same concentration of papaverine or sodium nitroprusside and particularly significant differences were identified under the concentration levels of 10−5 and 10−4 mol/L (P<0.01). The results suggest that the cGMP concentrations of the corpus cavernosum had been greatly reduced in CRF rabbits compared with control rabbits and that tadalafil may be an ideal medication for use in the treatment of CRF-related ED.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]Ahn, T.Y., Lee, S.W., Kim, S.W., Yang, D.Y., Park, N.C., Min, K.S., Park, K., Paick, J.S., Dyachkova, Y., Dwight, T., et al., 2007. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil. Asian J. Androl., 9(6):760-770.

[2]Bagcivan, I., Kilicarslan, H., Sarac, B., Gokce, G., Yildirim, S., Ayan, S., Sarioglu, Y., 2003. The evaluation of the effects of renal failure on erectile dysfunction in a rabbit model of chronic renal failure. BJU Int., 91(7):697-701.

[3]Barrou, B., Cuzin, B., Malavaud, B., Petit, J., Pariente, J.L., Buchler, M., Cormier, L., Benoit, G., Costa, P., 2003. Early experience with sildenafil for the treatment of erectile dysfunction in renal transplant recipients. Nephrol. Dial. Transplant., 18(2):411-417.

[4]Brock, G.B., McMahon, C.G., Chen, K.K., Costigan, T., Shen, W., Watkins, V., Anglin, G., Whitaker, S., 2002. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J. Urol., 168(1):1332-1336.

[5]Burnett, A.L., 2008. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J. Androl., 29(1):3-14.

[6]Chen, J., Mabjeesh, N.J., Greenstein, A., Nadu, A., Matzkin, H., 2001. Clinical efficacy of sildenafil in patients on chronic dialysis. J. Urol., 165(3):819-821.

[7]Eardley, I., Gentile, V., Austoni, E., Hackett, G., Lembo, D., Wang, C., Beardsworth, A., 2004. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. BJU Int., 94(6):871-877.

[8]Frajese, G.V., Pozzi, F., Frajese, G., 2006. Tadalafil in the treatment of erectile dysfunction: an overview of the clinical evidence. Clin. Interv. Aging, 1(4):439-449.

[9]Fu, Q., Yao, D.H., Jiang, Y.Q., 2000. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. Asian J. Androl., 2(4):301-313.

[10]Gratzke, C., Uckert, S., Kedia, G., Reich, O., Schlenker, B., Seitz, M., Becker, A.J., Stief, C.G., 2007. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach. Urol. Res., 35(1):49-54.

[11]Khan, M.A., Thompson, C.S., Jeremy, J.Y., Mumtaz, F.H., Mikhailidis, P., Morgan, R.J., 2001. The effect of superoxide dismutase on nitric oxide-mediated and electrical field-stimulated diabetic rabbit cavernosal smooth muscle relaxation. BJU Int., 87(1):98-103.

[12]Kilicarslan, H., Yildirim, S., Bagcivan, I., Ayan, S., Sarac, B., Sarioglu, Y., 2002. Effect of chronic renal failure on the purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int., 90(6):596-600.

[13]Kilicarslan, H., Yildirim, S., Bagcivan, I., Gokce, G., Sarac, B., Sarioglu, Y., 2003. The effect of chronic renal failure on phosphodiesterase inhibitor-induced relaxation responses in rabbit cavernosal strips. Eur. J. Pharmacol., 462(6):155-160.

[14]McCullough, A.R., Steidle, C.P., Klee, B., Tseng, L.J., 2008. Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose. Urology, 71(4):686-692.

[15]Mirone, V., Imbimbo, C., Rossi, A., Sicuteri, R., Valle, D., Longo, N., Fusco, F., 2007. Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy. Asian J. Androl., 9(3):395-402.

[16]Moncada, S., Palmer, R.M., Higgs, E.A., 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43(2):109-142.

[17]Montani, D., Chaumais, M.C., Savale, L., Natali, D., Price, L.C., Jaïs, X., Humbert, M., Simonneau, G., Sitbon, O., 2009. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Adv. Ther., 26(9):813-825.

[18]Nassir, A., 2009. Sexual function in male patients undergoing treatment for renal failure: a prospective view. J. Sex. Med., 6(12):3407-3414.

[19]Neto, A.F., de Freitas Rodrigues, M.A., Saraiva Fittipaldi, J.A., Moreira, E.D.Jr., 2002. The epidemiology of erectile dysfunction and its correlates in men with chronic renal failure on hemodialysis in Londrina, southern Brazil. Int. J. Impot. Res., 14(Suppl. 2):19-26.

[20]Shamloul, R., Atteya, A., Elnashaar, A., Gadallah, A., Zohdy, W., Abdelsalam, W., 2005. Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. J. Sex. Med., 2(1):117-120.

[21]Yip, W.C., Chiang, H.S., Mendoza, J.B., Tan, H.M., Li, M.K., Wang, W.C., Kopernicky, V., 2006. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study. Asian J. Androl., 8(6):685-692.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2022 Journal of Zhejiang University-SCIENCE